10x Genomics launched its Atera spatial platform at AACR 2026, positioning it as whole-transcriptome spatial biology at scale intended to reduce trade-offs seen in existing spatial tools. In addition to claims of higher throughput and multiplexing versus Xenium, the company laid out a pricing and availability plan: $495,000 with orders open and instrument availability in the second half of the year. The company also described Atera WTA and panel options with stackable 1,000-gene configurations, signaling a push to integrate spatial transcriptomics workflows into larger-scale research and translational pipelines.